Literature DB >> 29537700

Occurrence of Pseudomonas aeruginosa in waters: implications for patients with cystic fibrosis (CF).

S Caskey1, J Stirling2, J E Moore1,2, J C Rendall1.   

Abstract

Chronic Pseudomonas aeruginosa infection is associated with increased morbidity and mortality in patients with cystic fibrosis (CF). Current understanding of risk factors for acquisition is limited and so the aim of this study was to examine a large sample of environmental waters from diverse sources. Environmental water samples (n = 7904) from jacuzzis, hydrants, swimming pools, hot tubs, plunge pools, bottled natural mineral water, taps, springs, ice machines, water coolers, bores and showers were examined for the presence of P. aeruginosa. Pseudomonas aeruginosa was detected in 524/7904 (6·6%) waters examined. Hot tubs (51/243; 20·9%), tap water (3/40; 8%) and jacuzzis (432/5811; 7·4%) were the most likely environments where P. aeruginosa was isolated. Pseudomonas aeruginosa was isolated from bottled water (2/67; 3%). Our study highlights the ubiquitous nature of P. aeruginosa in the environment. Given CF patients are frequently counselled to make lifestyle changes to minimize P. aeruginosa exposure, these results have important implications. In particular, the occurrence of P. aeruginosa in tap water highlights the need to disinfect the CF patients' nebulizer after each use. SIGNIFICANCE AND IMPACT OF THE STUDY: This study examined a large number of water sources (n = 7904) over a 9-year period for the presence of Pseudomonas aeruginosa. The study highlighted that jacuzzis (n = 5811; 7% positive) and hot tubs had the highest occurrence of this organism (n = 243, 21% positive). Patients with cystic fibrosis (CF) are interested in knowing what water environments are likely to be contaminated with this organism, as this bacterium is an important cause of increased morbidity and mortality in such patients. With such information, CF patients and parents may make informed decisions about lifestyle choice and water environment avoidance.
© 2018 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Pseudomonas aeruginosazzm321990; cystic fibrosis; infection control; nebulizer; water

Mesh:

Substances:

Year:  2018        PMID: 29537700     DOI: 10.1111/lam.12876

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  6 in total

1.  A Gcn5-Related N-Acetyltransferase (GNAT) Capable of Acetylating Polymyxin B and Colistin Antibiotics in Vitro.

Authors:  Mateusz P Czub; Brian Zhang; M Paul Chiarelli; Karolina A Majorek; Layton Joe; Przemyslaw J Porebski; Alina Revilla; Weiming Wu; Daniel P Becker; Wladek Minor; Misty L Kuhn
Journal:  Biochemistry       Date:  2018-12-12       Impact factor: 3.162

2.  RegulomePA: a database of transcriptional regulatory interactions in Pseudomonas aeruginosa PAO1.

Authors:  Edgardo Galán-Vásquez; Beatriz Carely Luna-Olivera; Marcelino Ramírez-Ibáñez; Agustino Martínez-Antonio
Journal:  Database (Oxford)       Date:  2020-12-01       Impact factor: 3.451

3.  Pseudomonas aeruginosa in the Cystic Fibrosis Lung.

Authors:  John King; Ronan Murphy; Jane C Davies
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Nebuliser hygiene in cystic fibrosis: evidence-based recommendations.

Authors:  Jane Bell; Lauren Alexander; Jane Carson; Amanda Crossan; John McCaughan; Hazel Mills; Damian O'Neill; John E Moore; B Cherie Millar
Journal:  Breathe (Sheff)       Date:  2020-06

5.  Nebuliser cleaning and disinfection practice in the home among patients with cystic fibrosis.

Authors:  Mary MacFarlane; Lesley Carson; Amanda Crossan; Jane Bell; John E Moore; B Cherie Millar
Journal:  J Infect Prev       Date:  2019-06-21

6.  Contact Lens Use Patterns, Behavior and Knowledge Among University Students in Thailand.

Authors:  Chantaka Supiyaphun; Passara Jongkhajornpong
Journal:  Clin Ophthalmol       Date:  2021-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.